Colorectal Cancer Surgical Treatments
Colorectal cancer surgery has evolved well beyond simple tumor removal, with researchers now examining how treatments given before or after an operation — such as chemotherapy and radiation — can shrink tumors, reduce recurrence, and improve long-term survival. A key focus is rectal cancer, where total mesorectal excision, a precise surgical technique that removes the tumor along with its surrounding tissue envelope, has become the standard of care, often combined with neoadjuvant chemoradiotherapy to reduce the tumor before the surgeon operates. Minimally invasive approaches like laparoscopic surgery are being rigorously compared against open procedures for oncological adequacy and recovery outcomes, while tumor markers and measures of pathological response are under study as tools to predict which patients will benefit most from which treatment sequences. Central open questions include how to identify patients whose tumors respond so completely to neoadjuvant therapy that surgery might safely be deferred, and how to tailor adjuvant chemotherapy to individual risk rather than applying it uniformly across a heterogeneous patient population.
- Works
- 88,229
- Total citations
- 1,296,499
- Keywords
- Preoperative ChemoradiotherapyRectal CancerAdjuvant ChemotherapyLaparoscopic SurgeryTumor MarkersTotal Mesorectal Excision
Top papers in Colorectal Cancer Surgical Treatments
Ordered by total citation count.
- Classification of Surgical Complications↗ 30,556OA
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer↗ 10,955OA
- Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer↗ 6,033
- Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature↗ 5,275OA
- Colorectal cancer statistics, 2020↗ 5,104OA
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer↗ 5,044OA
- Colorectal cancer↗ 4,896OA
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer↗ 4,208OA
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer↗ 3,851OA
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer↗ 3,816
- The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping↗ 3,746OA
- Colorectal cancer statistics, 2023↗ 3,726OA
Active researchers
Top authors in this area, ranked by h-index.